Bojan Tepes
Overview
Explore the profile of Bojan Tepes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
368
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Casas Deza D, Alcedo J, Lafuente M, Lopez F, Perez-Aisa A, Pavoni M, et al.
Am J Gastroenterol
. 2025 Feb;
PMID: 39902822
Introduction: To evaluate the prescription patterns, effectiveness, and safety of adding probiotics to Helicobacter pylori eradication therapy, in Europe. Methods: International, prospective, noninterventional registry of the clinical practice of the...
2.
Olmedo L, Calvet X, Gene E, Bordin D, Voynovan I, Castro-Fernandez M, et al.
Gut
. 2024 Oct;
74(1):15-25.
PMID: 39461739
Background: Bismuth quadruple therapies (BQTs) including bismuth, a proton pump inhibitor (PPI) and two antibiotics have been shown to be highly effective for treating infection even in areas of high...
3.
Martinez-Dominguez S, Nyssen O, Lanas A, Alfaro E, Jonaitis L, Mahmudov U, et al.
Helicobacter
. 2024 Jul;
29(4):e13111.
PMID: 39001621
Background: The influence of indications for Helicobacter pylori investigation on prescriptions and effectiveness is unknown. The aim of the study was to assess the impact of indications for H. pylori...
4.
Huguet J, Ferrer-Barcelo L, Suarez P, Barcelo-Cerda S, Sempere J, Saracino I, et al.
United European Gastroenterol J
. 2024 Apr;
12(6):691-704.
PMID: 38685613
Background: Adherence to Helicobacter pylori (H. pylori) eradication treatment is a cornerstone for achieving adequate treatment efficacy. Objective: To determine which factors influence compliance with treatment. Methods: A systematic prospective...
5.
Pabon-Carrasco M, Keco-Huerga A, Castro-Fernandez M, Saracino I, Fiorini G, Vaira D, et al.
United European Gastroenterol J
. 2023 Dec;
12(1):122-138.
PMID: 38050339
Background: Management of Helicobacter pylori (H. pylori) infection requires co-treatment with proton pump inhibitors (PPIs) and the use of antibiotics to achieve successful eradication. Aim: To evaluate the role of...
6.
Bujanda L, Nyssen O, Ramos J, Bordin D, Tepes B, Perez-Aisa A, et al.
Am J Gastroenterol
. 2023 Nov;
119(4):646-654.
PMID: 37983769
Introduction: Antibiotic resistance is one of the main factors that determine the efficacy of treatments to eradicate Helicobacter pylori infection. Our aim was to evaluate the effectiveness of first-line and...
7.
Jonaitis P, Nyssen O, Saracino I, Fiorini G, Vaira D, Perez-Aisa A, et al.
Sci Rep
. 2023 Nov;
13(1):18821.
PMID: 37914853
No abstract available.
8.
Jonaitis P, Nyssen O, Saracino I, Fiorini G, Vaira D, Perez-Aisa A, et al.
Sci Rep
. 2023 Oct;
13(1):17235.
PMID: 37821503
The prevalence of Helicobacter pylori remains high in the older population. Specific age-related peculiarities may impact the outcomes of H. pylori treatment. The aim of the study was to evaluate...
9.
Nyssen O, Pratesi P, Spinola M, Jonaitis L, Perez-Aisa A, Vaira D, et al.
Antibiotics (Basel)
. 2023 Sep;
12(9).
PMID: 37760723
The segmentation of patients into homogeneous groups could help to improve eradication therapy effectiveness. Our aim was to determine the most important treatment strategies used in Europe, to evaluate first-line...
10.
Garcia-Morales N, Perez-Aisa A, Fiorini G, Tepes B, Castro-Fernandez M, Lucendo A, et al.
J Clin Med
. 2023 Jul;
12(13).
PMID: 37445399
Background And Aims: Several methods are available to diagnose infection. Our objective was to evaluate the tests used for both the initial diagnosis and the confirmation of eradication after treatment...